FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3105486182> ?p ?o ?g. }

• W3105486182 abstract "Abstract Exosome extracellular vesicles as biologic therapy for COVID‐19 are discussed for two areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the profound clinical cytokine storm and severe pneumonia in COVID‐19 patients. Instead, it is recommended to treat alternatively with their MSC‐released exosomes. This is because many reports in the literature and our data have shown that the release of exosomes from the in vivo administered MSC is actually responsible for their beneficial effects. Further, the exosomes are superior, simpler and clinically more convenient compared to their parental MSC. Additionally, in the context of COVID‐19, the known tendency of MSC to intravascularly aggregate causing lung dysfunction might synergize with the pneumonia aspects, and the tendency of MSC peripheral vascular micro aggregates might synergize with the vascular clots of the COVID‐19 disease process, causing significant central or peripheral vascular insufficiency. The second exosome therapeutic area for severe COVID‐19 involves use of convalescent plasma for its content of acquired immune antibodies that must consider the role in this therapy of contained nearly trillions of exosomes. Many of these derive from activated immune modulating cells and likely can function to transfer miRNAs that acting epigenetically to also influence the convalescent plasma recipient response to the virus. There is sufficient evidence, like recovery of patients with antibody deficiencies, to postulate that the antibodies actually have little effect and that immune resistance is principally due to T cell mechanisms. Further, COVID‐19 convalescent plasma has remarkably weak beneficial effects if compared to what was expected from many prior studies. This may be due to the dysfunctional immune response to the infection and resulting weak Ab that may be impaired further by antagonistic exosomes in the convalescent plasma. At the least, pre selection of plasma for the best antibodies and relevant exosomes would produce the most optimum therapy for very severely affected COVID‐19 patients." @default.
• W3105486182 created "2020-11-23" @default.
• W3105486182 creator A5052511743 @default.
• W3105486182 date "2020-11-01" @default.
• W3105486182 modified "2023-10-06" @default.
• W3105486182 title "COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?" @default.
• W3105486182 cites W1103823873 @default.
• W3105486182 cites W1492993345 @default.
• W3105486182 cites W1535490554 @default.
• W3105486182 cites W1945955401 @default.
• W3105486182 cites W1956428707 @default.
• W3105486182 cites W1965457368 @default.
• W3105486182 cites W1968806769 @default.
• W3105486182 cites W1996791478 @default.
• W3105486182 cites W2002827105 @default.
• W3105486182 cites W2005067857 @default.
• W3105486182 cites W2005315280 @default.
• W3105486182 cites W2011500268 @default.
• W3105486182 cites W2014734052 @default.
• W3105486182 cites W2027723253 @default.
• W3105486182 cites W2033850456 @default.
• W3105486182 cites W2038224079 @default.
• W3105486182 cites W2050290524 @default.
• W3105486182 cites W2057439500 @default.
• W3105486182 cites W2070528611 @default.
• W3105486182 cites W2085978024 @default.
• W3105486182 cites W2095320513 @default.
• W3105486182 cites W2096092997 @default.
• W3105486182 cites W2096238447 @default.
• W3105486182 cites W2110573496 @default.
• W3105486182 cites W2110763081 @default.
• W3105486182 cites W2115191828 @default.
• W3105486182 cites W2119095579 @default.
• W3105486182 cites W2126400039 @default.
• W3105486182 cites W2127148145 @default.
• W3105486182 cites W2133701960 @default.
• W3105486182 cites W2138201661 @default.
• W3105486182 cites W2148822770 @default.
• W3105486182 cites W2169492821 @default.
• W3105486182 cites W2169659972 @default.
• W3105486182 cites W2232354415 @default.
• W3105486182 cites W2340306432 @default.
• W3105486182 cites W2344378731 @default.
• W3105486182 cites W2460100043 @default.
• W3105486182 cites W2515904574 @default.
• W3105486182 cites W2529222684 @default.
• W3105486182 cites W2529648180 @default.
• W3105486182 cites W2554303625 @default.
• W3105486182 cites W2581268949 @default.
• W3105486182 cites W2582829456 @default.
• W3105486182 cites W2586436691 @default.
• W3105486182 cites W2591702058 @default.
• W3105486182 cites W2592109973 @default.
• W3105486182 cites W2602156496 @default.
• W3105486182 cites W2606603228 @default.
• W3105486182 cites W2612678922 @default.
• W3105486182 cites W2623131062 @default.
• W3105486182 cites W2753884258 @default.
• W3105486182 cites W2782372577 @default.
• W3105486182 cites W2793094247 @default.
• W3105486182 cites W2795369145 @default.
• W3105486182 cites W2802105343 @default.
• W3105486182 cites W2806593485 @default.
• W3105486182 cites W2808754971 @default.
• W3105486182 cites W2808784109 @default.
• W3105486182 cites W2886951904 @default.
• W3105486182 cites W2887249435 @default.
• W3105486182 cites W2890205877 @default.
• W3105486182 cites W2892283506 @default.
• W3105486182 cites W2893394744 @default.
• W3105486182 cites W2899470782 @default.
• W3105486182 cites W2900135008 @default.
• W3105486182 cites W2914833536 @default.
• W3105486182 cites W2919824502 @default.
• W3105486182 cites W2933304441 @default.
• W3105486182 cites W2934922729 @default.
• W3105486182 cites W2941318941 @default.
• W3105486182 cites W2943755588 @default.
• W3105486182 cites W2944971749 @default.
• W3105486182 cites W2946053206 @default.
• W3105486182 cites W2946172068 @default.
• W3105486182 cites W2952474297 @default.
• W3105486182 cites W2966266646 @default.
• W3105486182 cites W2969281902 @default.
• W3105486182 cites W2975889028 @default.
• W3105486182 cites W2977617462 @default.
• W3105486182 cites W2978883317 @default.
• W3105486182 cites W2981426204 @default.
• W3105486182 cites W2984313764 @default.
• W3105486182 cites W2984483284 @default.
• W3105486182 cites W2989678698 @default.
• W3105486182 cites W2990226146 @default.
• W3105486182 cites W2991491848 @default.
• W3105486182 cites W2996799736 @default.
• W3105486182 cites W3001214957 @default.
• W3105486182 cites W3002039811 @default.
• W3105486182 cites W3003179075 @default.
• W3105486182 cites W3003844576 @default.
• W3105486182 cites W3008551434 @default.
• W3105486182 cites W3009125272 @default.

• next